John M. Barberich
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di John M. Barberich
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Extinct | Pharmaceuticals: Other | 9 | |
Nordic Biotech Advisors ApS
 Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors.
3
| Private Company | Investment Managers | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a John M. Barberich tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Medical/Nursing Services | Founder | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Founder | |
Millenium Biologix Corp.
 Millenium Biologix Corp. BiotechnologyHealth Technology Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON. | Biotechnology | Director/Board Member Director/Board Member | |
| McGill University | College/University | Masters Business Admin | |
| Temple University (Pennsylvania) | College/University | Graduate Degree | |
| PYC THERAPEUTICS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| INSEAD | College/University | Undergraduate Degree | |
| Trinity College Dublin | College/University | Graduate Degree Undergraduate Degree | |
| Technical University of Denmark | College/University | Graduate Degree | |
Biocontrol Ltd. (United Kingdom)
 Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom. | Biotechnology | Director/Board Member | |
Virgin Health Bank Ltd.
 Virgin Health Bank Ltd. Medical/Nursing ServicesHealth Services Virgin Health Bank Ltd. provides umbilical cord blood stem cell banking services. It offers family banking and community banking. The company was founded in 2009 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
| FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| Eurobiotech, Inc. | Chief Executive Officer | ||
| NUCANA PLC | Biotechnology | Founder | |
Humanetix Pty Ltd.
 Humanetix Pty Ltd. Packaged SoftwareTechnology Services SmartWard Pty Ltd. develops software for the healthcare industry. The company was founded by Lindsay Bevege in 2012 and is headquartered in Bruce, Australia. | Packaged Software | Director/Board Member | |
| Cardiff University School of Medicine | College/University | Doctorate Degree | |
| Genethics Ltd. | Founder | ||
| Westminster School (United Kingdom) | College/University | Undergraduate Degree | |
CUBE Labs Srl
 CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Investment Managers | Consultant / Advisor | |
Deepbridge Capital LLP
 Deepbridge Capital LLP Investment ManagersFinance Deepbridge Capital LLP (Deepbridge) is an investment management firm founded in 2010. The firm is headquartered in Chester, UK. | Investment Managers | Consultant / Advisor | |
Vernalis Group, Inc.
 Vernalis Group, Inc. Packaged SoftwareTechnology Services Vernalis Group, Inc. provides custom software and tech solutions. | Packaged Software | Director/Board Member | |
| Rothchild Asset Management Uk | Corporate Officer/Principal | ||
EdixoMed Ltd.
 EdixoMed Ltd. BiotechnologyHealth Technology Part of Mativ Holdings, Inc., EdixoMed Ltd. engages in research and development of biotechnology. The company is based in Edinburgh, UK. The British company was founded by Hugh Stephen Griffith. | Biotechnology | Chairman | |
MedAnnex Ltd.
 MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Founder | |
| Oncobiopharm Ltd. | Chairman | ||
| Bioscience Managers Uk Ltd. | Investment Managers | Director/Board Member | |
Avena Therapeutics Ltd.
 Avena Therapeutics Ltd. BiotechnologyHealth Technology Avena Therapeutics Ltd. is a private company headquartered in Dublin, Ireland, that engages in research and experimental development on natural sciences and engineering. | Biotechnology | Chairman | |
Thirty Holdings Ltd.
 Thirty Holdings Ltd. Packaged SoftwareTechnology Services Thirty Holdings Ltd. operates as a holding British company whose subsidiary develops an anti-infective nitric oxide technology platform for the healthcare sector. The company is based in London, UK. The company was founded in 2018 by Christopher Barry Wood. | Packaged Software | Founder | |
| ARMATA PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
| LOBE SCIENCES LTD. | Agricultural Commodities/Milling | Chief Executive Officer Chief Operating Officer | |
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments. | Financial Conglomerates | Director/Board Member | |
| AVITA MEDICAL, INC. | Medical Specialties | Director/Board Member | |
TidalSense Ltd.
 TidalSense Ltd. Medical SpecialtiesHealth Technology Part of Gas Sensing Solutions Ltd., Cambridge Respiratory Innovations Ltd. develops and manufactures medical devices. The private company is based in Swavesey, UK. | Medical Specialties | Director/Board Member | |
GH Research Ireland Ltd.
 GH Research Ireland Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, GH Research Ireland Ltd. is an Irish clinical-stage biopharmaceutical company that develops innovative therapies for the treatment of mental illnesses. The company is based in Dublin, Ireland and is a subsidiary of GH Research Plc. | Miscellaneous Commercial Services | Chairman | |
| GH RESEARCH PLC | Pharmaceuticals: Major | Founder | |
| Gen Incode Ltd. | Director/Board Member | ||
| JLCC Ltd. | Director/Board Member | ||
| Marine Department Ltd. | Director/Board Member | ||
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Regno Unito | 22 |
| Stati Uniti | 12 |
| Canada | 5 |
| Irlanda | 5 |
| Danimarca | 4 |
Settori
| Health Technology | 24 |
| Consumer Services | 8 |
| Finance | 5 |
| Commercial Services | 4 |
| Technology Services | 4 |
Posizioni
| Director/Board Member | 98 |
| Chairman | 28 |
| Corporate Officer/Principal | 25 |
| Chief Executive Officer | 18 |
| Founder | 16 |
Contatti più connessi
| Insiders | |
|---|---|
| Jeremy Curnock-Cook | 60 |
| Bobby Sandage | 29 |
| Florian Schönharting | 17 |
| Christopher Barry Wood | 16 |
| Philip Young | 13 |
| Christian Hansen | 13 |
| Enda Kenny | 11 |
| Baxter Phillips | 8 |
| Wyle Solomon | 4 |
| Jennifer Glennon | 4 |
| David O'Flynn | 4 |
| Nathan Lassota | 1 |
- Borsa valori
- Insiders
- John M. Barberich
- Connessioni Società